Riparian Pharmaceuticals' Incubator/Accelerator - III Round

Riparian Pharmaceuticals raised a round of funding on July 12, 2017. Investors include Harvard Venture Incubation Program.

Riparian Pharmaceuticals is an early stage biotechnology company employing models of vascular pathology to discover therapeutics. The company explores therapeutics that would modify the biology within…

Articles about Riparian Pharmaceuticals' Incubator/Accelerator - III Round: